Skip to content

A Community-Based Chronic Disease Management Program Leveraging Smart Home Blood Pressure and Blood Glucose Monitoring

A Community-Based Chronic Disease Management Program Leveraging Smart Home Blood Pressure and Blood Glucose Monitoring

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500102426
Enrollment
Unknown
Registered
2025-05-14
Start date
2023-04-20
Completion date
Unknown
Last updated
2025-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

high blood pressure, diabetes

Interventions

Intervention groups:Hypertension and diabetes management model based on home remote blood pressure and blood glucose measurement
control subjects:Managed in accordance with the original routine management model for patients with hypertension and diabetes mellitus, doctors in community health service organizations complete four

Sponsors

Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patient inclusion criteria: patients aged 18-80 years with hypertension and diabetes mellitus under community-based management; patients with essential hypertension and type 2 diabetes mellitus who were registered for management at their community health services and continued to reside in the study community; patients who had been receiving stable antihypertensive or diabetic medications for 4 weeks or more at the time of entry into the trial and patients who had given informed consent.

Exclusion criteria

Exclusion criteria: Hypertensive patients: 1. those with blood pressure >=200/110 mm Hg (to avoid adverse events); 2. those with postural hypertension (systolic blood pressure rises >=20 mm Hg after the patient stands up) (to avoid adverse events); 3. those with secondary hypertension; 4. those who are taking >=3 types of medications to control blood pressure; 5. those who have existing target-organ damage; 6. those who have comorbidities with end-stage diseases such as tumors; 7. those who have dementia and cognitive impairment; 8. renal disease and hepatic dysfunction; 9. severe valvular heart disease, cardiomyopathy, unstable angina within 6 months, or coronary artery bypass grafting;10)unwilling to perform self-monitoring of blood pressure; 11. pregnant or planning to become pregnant (the treatment of blood pressure monitoring during pregnancy is different from that of the general patient); 12. participating in other trials. Patients with diabetes mellitus: 1. pregnant women; 2. patients with severe physical (dependence on others for mobility) or mental (active psychosis, major depression, communication disorders, etc.) illnesses, terminal illnesses, or other conditions that impede adherence (inability to care for themselves, alcohol dependence, or drug addiction, etc.); 3. hemoglobinopathies related to HbA1c; 4. a history of stroke or invasive revascularization; anticonvulsant therapy; 5. patients with type 1 diabetes or pancreatic insufficiency; and 6. participants in other trials.

Design outcomes

Primary

MeasureTime frame
systolic blood pressure;diastolic blood pressure;pulse pressure difference;Fasting Plasma Glucose (FPG);

Secondary

MeasureTime frame
Hypertension Patient Awareness;Level of self-management behaviors;Level of self-efficacy;

Countries

China

Contacts

Public ContactHui Li

Shandong University

huili@sdu.edu.cn+86 138 5314 9600

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026